![]() |
|
|
4
2 Neuronal Nicotinic
Acetylcholine Receptors by Cholinergic Channel Ligands and Second
Messenger Pathways
Neuroscience Research, Pharmaceutical Products Division, Abbott
Laboratories, Abbott Park, Illinois 60064-3500
The
4
2 nicotinic acetylcholine receptors (nAChRs), a major
subtype in the brain, have been shown to be modulated by chronic treatment with nicotine. In this study, the regulation of recombinant human
4
2 nAChR subtype by (
)-nicotine and other cholinergic channel modulators was studied using human embryonic kidney 293 cells
stably expressing this subunit combination. The treatment of
transfected cells with (
)-nicotine and other activator ligands, including (
)-cytisine, 1,1-dimethyl-4-phenylpiperazinium,
(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and
(±)-epibatidine, resulted in concentration-dependent increases in the
levels of
4
2 nAChRs. The increase in [3H]cytisine
binding sites was initiated by low concentrations of (
)-nicotine
(<100 nM); was maximal at 10 µM (15-fold),
rapid (t0.5 = 4.0 ± 0.5 hr), and totally
reversible (t0.5 = 11.7 ± 0.1 hr); and
occurred with no change in ligand binding affinity. Antagonists, including dihydro-
-erythroidine, d-tubocurarine, and
methyllycaconitine, also elicited significant increases in receptor
levels. A good correlation was observed between the
Ki values for binding inhibition and
the EC50 values for receptor up-regulation. Treatment of
cells with mecamy-lamine, a noncompetitive antagonist, did not change receptor levels or alter (
)-nicotine-evoked up-regulation.
(
)-Nicotine-evoked up-regulation was blocked by cycloheximide,
suggesting a role for protein synthesis. Treatment of cells with
(
)-nicotine or dihydro-
-erythroidine differentially modulated the
efficacy of acetylcholine to activate cation efflux. Both
6-
-[
(piperidino)propionyl]forskolin and
phorbol-12-myristate-13-acetate increased [3H]cytisine
binding sites and nAChR function and enhanced the effects of chronic
(
)-nicotine treatment in a synergistic manner. These results
collectively demonstrate that human
4
2 nAChRs can be differentially up-regulated by chronic treatment with nAChR ligands and
activation of protein kinase A- and protein kinase C-dependent mechanisms.
This article has been cited by other articles:
![]() |
A. G. Mukhin, A. S. Kimes, S. I. Chefer, J. A. Matochik, C. S. Contoreggi, A. G. Horti, D. B. Vaupel, O. Pavlova, and E. A. Stein Greater Nicotinic Acetylcholine Receptor Density in Smokers Than in Nonsmokers: A PET Study with 2-18F-FA-85380 J. Nucl. Med., October 1, 2008; 49(10): 1628 - 1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Gahring, A. V. Osborne-Hereford, G. A. Vasquez-Opazo, and S. W. Rogers Tumor Necrosis Factor {alpha} Enhances Nicotinic Receptor Up-regulation via a p38MAPK-dependent Pathway J. Biol. Chem., January 11, 2008; 283(2): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kishi and J. H. Steinbach Role of the Agonist Binding Site in Up-Regulation of Neuronal Nicotinic {alpha}4beta2 Receptors Mol. Pharmacol., December 1, 2006; 70(6): 2037 - 2044. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xiao, H. Fan, J. L. Musachio, Z.-L. Wei, S. K. Chellappan, A. P. Kozikowski, and K. J. Kellar Sazetidine-A, A Novel Ligand That Desensitizes {alpha}4beta2 Nicotinic Acetylcholine Receptors without Activating Them Mol. Pharmacol., October 1, 2006; 70(4): 1454 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Raiteri Functional pharmacology in human brain. Pharmacol. Rev., June 1, 2006; 58(2): 162 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kuryatov, J. Luo, J. Cooper, and J. Lindstrom Nicotine Acts as a Pharmacological Chaperone to Up-Regulate Human {alpha}4{beta}2 Acetylcholine Receptors Mol. Pharmacol., December 1, 2005; 68(6): 1839 - 1851. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Ficklin, S. Zhao, and G. Feng Ubiquilin-1 Regulates Nicotine-induced Up-regulation of Neuronal Nicotinic Acetylcholine Receptors J. Biol. Chem., October 7, 2005; 280(40): 34088 - 34095. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. F. Vallejo, B. Buisson, D. Bertrand, and W. N. Green Chronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism J. Neurosci., June 8, 2005; 25(23): 5563 - 5572. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Darsow, T. K. Booker, J. C. Pina-Crespo, and S. F. Heinemann Exocytic Trafficking Is Required for Nicotine-induced Up-regulation of {alpha}4{beta}2 Nicotinic Acetylcholine Receptors J. Biol. Chem., May 6, 2005; 280(18): 18311 - 18320. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Y. Lopez-Hernandez, J. Sanchez-Padilla, A. Ortiz-Acevedo, J. Lizardi-Ortiz, J. Salas-Vincenty, L. V. Rojas, and J. A. Lasalde-Dominicci Nicotine-induced Up-regulation and Desensitization of {alpha}4{beta}2 Neuronal Nicotinic Receptors Depend on Subunit Ratio J. Biol. Chem., September 3, 2004; 279(36): 38007 - 38015. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sallette, S. Bohler, P. Benoit, M. Soudant, S. Pons, N. Le Novere, J.-P. Changeux, and P. J. Corringer An Extracellular Protein Microdomain Controls Up-regulation of Neuronal Nicotinic Acetylcholine Receptors by Nicotine J. Biol. Chem., April 30, 2004; 279(18): 18767 - 18775. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Eaton, J.-H. Peng, K. M. Schroeder, A. A. George, J. D. Fryer, C. Krishnan, L. Buhlman, Y.-P. Kuo, O. Steinlein, and R. J. Lukas Characterization of Human {alpha}4{beta}2-Nicotinic Acetylcholine Receptors Stably and Heterologously Expressed in Native Nicotinic Receptor-Null SH-EP1 Human Epithelial Cells Mol. Pharmacol., December 1, 2003; 64(6): 1283 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Gentry, L. H. Wilkins Jr., and R. J. Lukas Effects of Prolonged Nicotinic Ligand Exposure on Function of Heterologously Expressed, Human alpha 4beta 2- and alpha 4beta 4-Nicotinic Acetylcholine Receptors J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 206 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Harkness and N. S. Millar Changes in Conformation and Subcellular Distribution of alpha 4beta 2 Nicotinic Acetylcholine Receptors Revealed by Chronic Nicotine Treatment and Expression of Subunit Chimeras J. Neurosci., December 1, 2002; 22(23): 10172 - 10181. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lin, E. M. Jeanclos, M. Treuil, K.-H. Braunewell, E. D. Gundelfinger, and R. Anand The Calcium Sensor Protein Visinin-like Protein-1 Modulates the Surface Expression and Agonist Sensitivity of the alpha 4beta 2 Nicotinic Acetylcholine Receptor J. Biol. Chem., October 25, 2002; 277(44): 41872 - 41878. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Katsura, Y. Mohri, K. Shuto, Y. Hai-Du, T. Amano, A. Tsujimura, M. Sasa, and S. Ohkuma Up-regulation of L-type Voltage-dependent Calcium Channels after Long Term Exposure to Nicotine in Cerebral Cortical Neurons J. Biol. Chem., March 1, 2002; 277(10): 7979 - 7988. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hilmas, E. F. R. Pereira, M. Alkondon, A. Rassoulpour, R. Schwarcz, and E. X. Albuquerque The Brain Metabolite Kynurenic Acid Inhibits {alpha}7 Nicotinic Receptor Activity and Increases Non-{alpha}7 Nicotinic Receptor Expression: Physiopathological Implications J. Neurosci., October 1, 2001; 21(19): 7463 - 7473. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Buisson and D. Bertrand Chronic Exposure to Nicotine Upregulates the Human {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Function J. Neurosci., March 15, 2001; 21(6): 1819 - 1829. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Fenster, T. L. Whitworth, E. B. Sheffield, M. W. Quick, and R. A. J. Lester Upregulation of Surface alpha 4beta 2 Nicotinic Receptors Is Initiated by Receptor Desensitization after Chronic Exposure to Nicotine J. Neurosci., June 15, 1999; 19(12): 4804 - 4814. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Fenster, M. L. Beckman, J. C. Parker, E. B. Sheffield, T. L. Whitworth, M. W. Quick, and R. A. J. Lester Regulation of alpha 4beta 2 Nicotinic Receptor Desensitization by Calcium and Protein Kinase C Mol. Pharmacol., March 1, 1999; 55(3): 432 - 443. [Abstract] [Full Text] |
||||
![]() |
F. Wang, M. E. Nelson, A. Kuryatov, F. Olale, J. Cooper, K. Keyser, and J. Lindstrom Chronic Nicotine Treatment Up-regulates Human alpha 3beta 2 but Not alpha 3beta 4 Acetylcholine Receptors Stably Transfected in Human Embryonic Kidney Cells J. Biol. Chem., October 30, 1998; 273(44): 28721 - 28732. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Whiteaker, C. G. V. Sharples, and S. Wonnacott Agonist-Induced Up-Regulation of alpha 4beta 2 Nicotinic Acetylcholine Receptors in M10 Cells: Pharmacological and Spatial Definition Mol. Pharmacol., May 1, 1998; 53(5): 950 - 962. [Abstract] [Full Text] |
||||
![]() |
E. M. Jeanclos, L. Lin, M. W. Treuil, J. Rao, M. A. DeCoster, and R. Anand The Chaperone Protein 14-3-3eta Interacts with the Nicotinic Acetylcholine Receptor alpha 4 Subunit. EVIDENCE FOR A DYNAMIC ROLE IN SUBUNIT STABILIZATION J. Biol. Chem., July 20, 2001; 276(30): 28281 - 28290. [Abstract] [Full Text] [PDF] |
||||